Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends
By EsqSocial Corporation 23/12/24
Since the previous quarter’s Life Sciences Snapshot, robust dealmaking activity in Q3 has launched YTD life sciences VC deal activity to near parity with 2023 figures, firmly positioning 2024 as the year to break the two-year declines in venture activity. This report series examines quarterly trends in life sciences venture investments, and the key takeaways include......
By: Orrick, Herrington & Sutcliffe LLP